# Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-sintilimab-and-chemotherapy-in-patients-with-potentially-resectable/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xiaofeng Chen,Xiang Xu,Danping Wang,Jinyuan Liu,Jing Ping Sun,Mingjie Lu,Rui Wang,Bingqing Hui,Xiaofei Li,Chenchen Zhou,Min Wang,Tianzhu Qiu,Shiyun Cui,Nana Sun,Yang Li,Fufeng Wang,Cuicui Liu,Yang Shao,Jinhua Luo,Yanhong Gu |
| Citations | 108 |
| DOI | 10.1136/jitc-2022-005830 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jitc.bmj.com/content/jitc/11/2/e005830.full.pdf |
| OpenAlex ID | https://openalex.org/W4319787613 |
| PMID | 36759013 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Rui Wang](https://scholariq.org/researchers/rui-wang/)

## Paper primary topic

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

## Paper topics

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.